86.64
price down icon1.74%   -1.53
after-market Handel nachbörslich: 86.64
loading

Finanzdaten der Vaxcyte Inc-Aktie (PCVX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
41.80%
114.47
196.68 113.03 87.15 71.19
Depreciation and Amortization
11.11%
1.00
0.90 0.80 0.80 0.70
Operating Income/Loss
41.80%
-114.47
-196.68 -113.03 -87.15 -71.19
Income/Loss From Continuing Operations Before Tax
47.44%
-95.02
-180.80 -92.66 -68.34 -60.46
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
47.44%
-95.02
-180.80 -92.66 -68.34 -60.46
Net Income/Loss
47.44%
-95.02
-180.80 -92.66 -68.34 -60.46
Preferred Stock Dividends And Other Adjustments
100.00%
-
442.93 -185.33 - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
6,140%
111.69
1.7899 101.67 98.06 86.21
Diluted Average Shares
6,140%
111.69
1.7899 101.67 98.06 86.21
Basic Earnings Per Share
53.30%
-0.85
-1.82 -0.91 -0.70 -0.70
Diluted Earnings Per Share
53.30%
-0.85
-1.82 -0.91 -0.70 -0.70
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
100.00%
-
442.93 -185.33 - -
$72.41
price down icon 1.44%
$38.50
price up icon 7.27%
$371.28
price up icon 0.90%
$23.52
price up icon 6.43%
biotechnology ONC
$222.22
price up icon 1.61%
$115.17
price down icon 1.77%
Kapitalisierung:     |  Volumen (24h):